Drug maker Dr Reddy's Laboratories Ltd on Friday said that it has received the US Food and Drug Administration (FDA) approval to launch an injection 'ZEMBRACE SymTouch' meant for migraine treatment. Notably, this is the company's first product in the neurology portfolio. The drug will be marketed in the US by Promius Pharma, a fully-owned subsidiary of Dr Reddy's Laboratories.  